Caseware UK (AP4) 2025.0.111 2025.0.111 2026-03-31 2026-03-31 2025-04-06 true Exemption - section 477 of the Companies Act 2006 false No description of principal activity 68 69 true true false 09146517 2025-04-06 2026-03-31 09146517 2024-04-01 2025-04-05 09146517 2026-03-31 09146517 2025-04-05 09146517 c:Director2 2025-04-06 2026-03-31 09146517 d:Buildings 2025-04-06 2026-03-31 09146517 d:Buildings 2026-03-31 09146517 d:Buildings 2025-04-05 09146517 d:Buildings d:OwnedOrFreeholdAssets 2025-04-06 2026-03-31 09146517 d:MotorVehicles 2025-04-06 2026-03-31 09146517 d:MotorVehicles 2026-03-31 09146517 d:MotorVehicles 2025-04-05 09146517 d:MotorVehicles d:OwnedOrFreeholdAssets 2025-04-06 2026-03-31 09146517 d:FurnitureFittings 2025-04-06 2026-03-31 09146517 d:FurnitureFittings 2026-03-31 09146517 d:FurnitureFittings 2025-04-05 09146517 d:FurnitureFittings d:OwnedOrFreeholdAssets 2025-04-06 2026-03-31 09146517 d:OfficeEquipment 2025-04-06 2026-03-31 09146517 d:OfficeEquipment 2026-03-31 09146517 d:OfficeEquipment 2025-04-05 09146517 d:OfficeEquipment d:OwnedOrFreeholdAssets 2025-04-06 2026-03-31 09146517 d:OwnedOrFreeholdAssets 2025-04-06 2026-03-31 09146517 d:FreeholdInvestmentProperty 2025-04-06 2026-03-31 09146517 d:FreeholdInvestmentProperty 2026-03-31 09146517 d:FreeholdInvestmentProperty 2025-04-05 09146517 d:FreeholdInvestmentProperty 2 2025-04-06 2026-03-31 09146517 d:CurrentFinancialInstruments 2026-03-31 09146517 d:CurrentFinancialInstruments 2025-04-05 09146517 d:Non-currentFinancialInstruments 2026-03-31 09146517 d:Non-currentFinancialInstruments 2025-04-05 09146517 d:CurrentFinancialInstruments d:WithinOneYear 2026-03-31 09146517 d:CurrentFinancialInstruments d:WithinOneYear 2025-04-05 09146517 d:Non-currentFinancialInstruments d:AfterOneYear 2026-03-31 09146517 d:Non-currentFinancialInstruments d:AfterOneYear 2025-04-05 09146517 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2026-03-31 09146517 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2025-04-05 09146517 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2026-03-31 09146517 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2025-04-05 09146517 d:Non-currentFinancialInstruments d:MoreThanFiveYears 2026-03-31 09146517 d:Non-currentFinancialInstruments d:MoreThanFiveYears 2025-04-05 09146517 d:ShareCapital 2026-03-31 09146517 d:ShareCapital 2025-04-05 09146517 d:RetainedEarningsAccumulatedLosses 2026-03-31 09146517 d:RetainedEarningsAccumulatedLosses 2025-04-05 09146517 d:AcceleratedTaxDepreciationDeferredTax 2026-03-31 09146517 d:AcceleratedTaxDepreciationDeferredTax 2025-04-05 09146517 d:RetirementBenefitObligationsDeferredTax 2026-03-31 09146517 d:RetirementBenefitObligationsDeferredTax 2025-04-05 09146517 d:OtherDeferredTax 2026-03-31 09146517 d:OtherDeferredTax 2025-04-05 09146517 c:OrdinaryShareClass1 2025-04-06 2026-03-31 09146517 c:OrdinaryShareClass1 2026-03-31 09146517 c:OrdinaryShareClass1 2025-04-05 09146517 c:OrdinaryShareClass2 2025-04-06 2026-03-31 09146517 c:OrdinaryShareClass2 2026-03-31 09146517 c:OrdinaryShareClass2 2025-04-05 09146517 c:FRS102 2025-04-06 2026-03-31 09146517 c:AuditExemptWithAccountantsReport 2025-04-06 2026-03-31 09146517 c:FullAccounts 2025-04-06 2026-03-31 09146517 c:PrivateLimitedCompanyLtd 2025-04-06 2026-03-31 09146517 2 2025-04-06 2026-03-31 09146517 f:PoundSterling 2025-04-06 2026-03-31 iso4217:GBP xbrli:shares xbrli:pure

| Registered number: 09146517
CROWNWOOD HEALTHCARE (TEMPLE EWELL) LIMITED UNAUDITED ANNUAL REPORT AND FINANCIAL STATEMENTS INFORMATION FOR FILING WITH THE REGISTRAR FOR THE PERIOD ENDED 31 MARCH 2026
CROWNWOOD HEALTHCARE (TEMPLE EWELL) LIMITED CHARTERED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF CROWNWOOD HEALTHCARE (TEMPLE EWELL) LIMITED FOR THE PERIOD ENDED 31 MARCH 2026 In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Crownwood Healthcare (Temple Ewell) Limited for the period ended 31 March 2026 which comprise the Statement of financial position and the related notes from the Company's accounting records and from information and explanations you have given us. As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com /regulation. This report is made solely to the Board of directors of Crownwood Healthcare (Temple Ewell) Limited, as a body, in accordance with the terms of our engagement letter dated 22 August 2025. Our work has been undertaken solely to prepare for your approval the financial statements of Crownwood Healthcare (Temple Ewell) Limited and state those matters that we have agreed to state to the Board of directors of Crownwood Healthcare (Temple Ewell) Limited, as a body, in this report in accordance with ICAEW Technical Release TECH07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Crownwood Healthcare (Temple Ewell) Limited and its Board of directors, as a body, for our work or for this report. It is your duty to ensure that Crownwood Healthcare (Temple Ewell) Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Crownwood Healthcare (Temple Ewell) Limited. You consider that Crownwood Healthcare (Temple Ewell) Limited is exempt from the statutory audit requirement for the period. We have not been instructed to carry out an audit or review of the financial statements of Crownwood Healthcare (Temple Ewell) Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements. Bishop Fleming LLP Chartered Accountants Brook House Manor Drive Clyst St Mary Exeter EX5 1GD 6 July 2026 Page 1
CROWNWOOD HEALTHCARE (TEMPLE EWELL) LIMITED REGISTERED NUMBER:09146517 STATEMENT OF FINANCIAL POSITION AS AT 31 MARCH 2026
|  | 31 March |  | 5 April
|  | 2026 |  | 2025
Note |  | £ |  | £
Fixed assets |  |  |  |  |
Tangible assets | 4 |  | 2,528,386 |  | 2,351,091
Investment property | 5 |  | - |  | 279,636
|  |  | 2,528,386 |  | 2,630,727
Current assets |  |  |  |  |
Debtors: amounts falling due within one year | 6 | 2,569,037 |  | 1,336,984 |
Cash at bank and in hand |  | 321,790 |  | 288,635 |
|  | 2,890,827 |  | 1,625,619 |
Creditors: amounts falling due within one year | 7 | (1,293,374) |  | (2,504,867) |
Net current assets/(liabilities) |  |  | 1,597,453 |  | (879,248)
Total assets less current liabilities |  |  | 4,125,839 |  | 1,751,479
Creditors: amounts falling due after more than one year | 8 |  | (2,068,535) |  | (51,360)
Provisions for liabilities |  |  |  |  |
Deferred tax | 10 | (201,253) |  | (173,325) |
Net assets |  |  | 1,856,051 |  | 1,526,794
Capital and reserves |  |  |  |  |
Called up share capital | 11 |  | 101 |  | 101
Profit and loss account |  |  | 1,855,950 |  | 1,526,693
|  |  | 1,856,051 |  | 1,526,794
Page 2
CROWNWOOD HEALTHCARE (TEMPLE EWELL) LIMITED REGISTERED NUMBER:09146517 STATEMENT OF FINANCIAL POSITION (CONTINUED) AS AT 31 MARCH 2026 The directors consider that the Company is entitled to exemption from audit under section 479A of the Companies Act 2006. The members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements. The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities. The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime. The financial statements were approved and authorised for issue by the board and were signed on its behalf by:
Mitesh Kunvarji
Director
Date: 6 July 2026
The notes on pages 4 to 13 form part of these financial statements. Page 3
CROWNWOOD HEALTHCARE (TEMPLE EWELL) LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 MARCH 2026
1. | GENERAL INFORMATION
Crownwood Healthcare (Temple Ewell) Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Century House, Nicholson Road, Torquay, TQ2 7TD, England, United Kingdom. The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £. 2.ACCOUNTING POLICIES
| 2.1 | BASIS OF PREPARATION OF FINANCIAL STATEMENTS
The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view. The following principal accounting policies have been applied:
| 2.2 | GOING CONCERN
The directors have assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.
| 2.3 | REPORTING PERIOD LENGTH
The comparative period presented in the prior year financial statements covered a period of one year and five days, whereas the current reporting period comprises 360 days. Accordingly, the current and comparative figures are not directly comparable. Page 4
CROWNWOOD HEALTHCARE (TEMPLE EWELL) LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 MARCH 2026 2.ACCOUNTING POLICIES (CONTINUED)
| 2.4 | REVENUE
Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised: Rendering of services Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied: ∙the amount of revenue can be measured reliably; ∙it is probable that the Company will receive the consideration due under the contract; ∙the stage of completion of the contract at the end of the reporting period can be measured reliably; and ∙the costs incurred and the costs to complete the contract can be measured reliably.
| 2.5 | OPERATING LEASES: THE COMPANY AS LESSOR
Rental income from operating leases is credited to profit or loss on a straight-line basis over the lease term. Amounts paid and payable as an incentive to sign an operating lease are recognised as a reduction to income over the lease term on a straight-line basis, unless another systematic basis is representative of the time pattern over which the lessor's benefit from the leased asset is diminished.
| 2.6 | GOVERNMENT GRANTS
Grants are accounted under the accruals model as permitted by FRS 102. Grants relating to expenditure on tangible fixed assets are credited to profit or loss at the same rate as the depreciation on the assets to which the grant relates. The deferred element of grants is included in creditors as deferred income. Grants of a revenue nature are recognised in the Statement of income and retained earnings in the same period as the related expenditure.
| 2.7 | INTEREST INCOME
Interest income is recognised in profit or loss using the effective interest method.
| 2.8 | FINANCE COSTS
Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.
| 2.9 | BORROWING COSTS
All borrowing costs are recognised in profit or loss in the period in which they are incurred. Page 5
CROWNWOOD HEALTHCARE (TEMPLE EWELL) LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 MARCH 2026 2.ACCOUNTING POLICIES (CONTINUED)
| 2.10 | PENSIONS
DEFINED CONTRIBUTION PENSION PLAN The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations. The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of financial position. The assets of the plan are held separately from the Company in independently administered funds.
| 2.11 | CURRENT AND DEFERRED TAXATION
The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively. The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income. Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that: ∙The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and ∙Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met. Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.
| 2.12 | TANGIBLE FIXED ASSETS
Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management. Page 6
CROWNWOOD HEALTHCARE (TEMPLE EWELL) LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 MARCH 2026 2.ACCOUNTING POLICIES (CONTINUED)
| 2.12 | TANGIBLE FIXED ASSETS (CONTINUED)
Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, either straight line or reducing balance basis. Depreciation is provided on the following basis:
|  |  |  | Freehold property | - | 50 years straight line
|  |  |  | Motor vehicles | - | 4 years straight line
|  |  |  | Fixtures and fittings | - | 15% reducing balance
|  |  |  | Office equipment | - | 25% reducing balance
The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date. Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.
| 2.13 | INVESTMENT PROPERTY
Investment property is carried at fair value determined annually by the directors and derived from the current market rents and investment property yields for comparable real estate, adjusted if necessary for any difference in the nature, location or condition of the specific asset. No depreciation is provided. Changes in fair value are recognised in profit or loss.
| 2.14 | DEBTORS
Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.
| 2.15 | CASH AND CASH EQUIVALENTS
Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.
| 2.16 | CREDITORS
Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
| 2.17 | PROVISIONS FOR LIABILITIES
Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made. Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties. Increases in provisions are generally charged as an expense to profit or loss. Page 7
CROWNWOOD HEALTHCARE (TEMPLE EWELL) LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 MARCH 2026 2.ACCOUNTING POLICIES (CONTINUED)
| 2.18 | FINANCIAL INSTRUMENTS
The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments. Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument. Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities. Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.
| 2.19 | DIVIDENDS
Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.
| 2.20 | SHARE CAPITAL
The ordinary share capital of the Company is presented as equity.
3. | EMPLOYEES
The average monthly number of employees, including directors, during the period was 68 (2025: 69). Page 8
CROWNWOOD HEALTHCARE (TEMPLE EWELL) LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 MARCH 2026
4. | TANGIBLE FIXED ASSETS
|  | Freehold property | Motor vehicles | Fixtures and fittings | Office equipment | Total
|  | £ | £ | £ | £ | £
| COST |  |  |  |  |
| At 6 April 2025 | 2,202,208 | 62,292 | 429,380 | 33,360 | 2,727,240
| Additions | 156,738 | 79,468 | 47,121 | 8,876 | 292,203
| At 31 March 2026 | 2,358,946 | 141,760 | 476,501 | 42,236 | 3,019,443
| DEPRECIATION |  |  |  |  |
| At 6 April 2025 | 114,554 | 12,978 | 227,149 | 21,468 | 376,149
| Charge for the period on owned assets | 45,514 | 30,473 | 34,689 | 4,232 | 114,908
| At 31 March 2026 | 160,068 | 43,451 | 261,838 | 25,700 | 491,057
| NET BOOK VALUE |  |  |  |  |
| At 31 March 2026 | 2,198,878 | 98,309 | 214,663 | 16,536 | 2,528,386
| At 5 April 2025 | 2,087,654 | 49,314 | 202,231 | 11,892 | 2,351,091
5. | INVESTMENT PROPERTY
|  | Freehold investment property
|  | £
| At 6 April 2025 | 279,636
| Disposals | (350,000)
| Surplus on revaluation | 70,364
| AT 31 MARCH 2026 | -
The 2026 valuations were made by Davis Coffer Lyons, on an open market value for existing use basis.
Page 9
CROWNWOOD HEALTHCARE (TEMPLE EWELL) LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 MARCH 2026
6. | DEBTORS
|  |  |  |  | 31 March | 5 April
|  |  |  |  | 2026 | 2025
|  |  |  |  | £ | £
| Amounts owed by group undertakings | 709,757 | 214,216
| Other debtors | 1,658,031 | 1,044,860
| Prepayments and accrued income | 201,249 | 77,908
|  | 2,569,037 | 1,336,984
7. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
|  |  |  |  | 31 March | 5 April
|  |  |  |  | 2026 | 2025
|  |  |  |  | £ | £
| Bank loans (Secured) | 6,201 | 10,468
| Trade creditors | 121,623 | 64,483
| Amounts owed to group undertakings | 600,284 | 2,048,141
| Corporation tax | 175,400 | 60,994
| Other taxation and social security | 48,822 | 29,826
| Obligations under finance lease and hire purchase contracts (Secured) | 21,873 | 12,769
| Other creditors | 308,091 | 233,551
| Accruals and deferred income | 11,080 | 44,635
|  | 1,293,374 | 2,504,867
| The Triodos bank loans above are secured by way of a first legal mortgage over the company’s freehold properties, fixed charges over certain assets including plant and equipment, receivables, intellectual property and cash balances, and a floating charge over the remainder of the company’s undertaking and assets.
8. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
|  |  |  |  | 31 March | 5 April
|  |  |  |  | 2026 | 2025
|  |  |  |  | £ | £
| Bank loans (Secured) | 1,975,177 | 1,769
| Net obligations under finance leases and hire purchase contracts (Secured) | 93,358 | 49,591
|  | 2,068,535 | 51,360
| The Triodos bank loans above are secured by way of a first legal mortgage over the company’s freehold properties, fixed charges over certain assets including plant and equipment, receivables, intellectual property and cash balances, and a floating charge over the remainder of the company’s undertaking and assets.
Page 10
CROWNWOOD HEALTHCARE (TEMPLE EWELL) LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 MARCH 2026
9. | LOANS
| Analysis of the maturity of loans is given below:
|  |  |  |  | 31 March | 5 April
|  |  |  |  | 2026 | 2025
|  |  |  |  | £ | £
| AMOUNTS FALLING DUE WITHIN ONE YEAR |  |
| Bank loans | 6,201 | 10,468
| AMOUNTS FALLING DUE 1-2 YEARS |  |
| Bank loans | 100,758 | 1,769
| AMOUNTS FALLING DUE 2-5 YEARS |  |
| Bank loans | 151,137 | -
| AMOUNTS FALLING DUE AFTER MORE THAN 5 YEARS |  |
| Bank loans | 1,723,281 | -
|  | 1,981,377 | 12,237
10. | DEFERRED TAXATION
|  | 2026
|  | £
| At beginning of year | (173,325)
| Charged to profit or loss | (27,928)
| AT END OF YEAR | (201,253)
| The provision for deferred taxation is made up as follows:
|  |  |  |  | 31 March | 5 April
|  |  |  |  | 2026 | 2025
|  |  |  |  | £ | £
| Fixed asset timing differences | (201,956) | (170,687)
| Short term timing differences | 703 | 1,237
| Capital gains/(losses) | - | (3,875)
|  | (201,253) | (173,325)
Page 11
CROWNWOOD HEALTHCARE (TEMPLE EWELL) LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 MARCH 2026
11. | SHARE CAPITAL
|  |  |  |  | 31 March | 5 April
|  |  |  |  | 2026 | 2025
|  |  |  |  | £ | £
|  | ALLOTTED, CALLED UP AND FULLY PAID |  |
|  | 100 (2025: 100) Ordinary shares of £1.00 each | 100 | 100
|  | 1 (2025: 1) Redeemable Preference share of £1.00 | 1 | 1
|  |  | 101 | 101
12. | PENSION COMMITMENTS
The Company operates a defined contribution pension scheme for the directors and employees. The assets of the scheme are held separately from those of the Company in an independently administered fund. Unpaid contributions due to the fund (included within other creditors) is £6,477 (2025: £11,980).
13. | RELATED PARTY TRANSACTIONS
| As a wholly owned subsidiary undertaking of their parent company, Crownwood Healthcare (Holdings) Limited, (Registered office: Century House, Nicholson Road, Torquay, TQ2 7TD, England, United Kingdom), the company has taken advantage of the exemption per Section 33 of FRS 102 in not disclosing intra group transactions where 100% of the voting rights are controlled within the group. Transactions with owners holding a participating interest in the entity and transactions with the entity's directors:
|  | 31 March | 5 April
|  | 2026 | 2025
|  | £ | £
| Balances owed (to) the Directors | (81,679) | (160,814)
| Balances owed from the Directors | 186,877 | 114,982
| Amounts owed by connected companies, held in other debtors | 393,120 | 350,461
|  | 498,318 | 304,629
| Interest has been charged on the overdrawn balances at HMRC's official rate and there is no fixed date for repayment. Bank Loans The Company has entered into a debenture with Triodos Bank UK Limited alongside other group undertakings. Under the terms of this arrangement, the Company and certain fellow group entities have provided cross-collateralised security in respect of the group’s borrowings. The security granted includes a first legal mortgage over the Company’s freehold land and buildings, together with fixed charges over specified assets including plant and machinery, and a floating charge over all other assets and undertaking of the Company. The debenture also includes a negative pledge restricting the creation of further security. Accordingly, the tangible fixed assets of the Company are subject to these security arrangements.
Page 12
CROWNWOOD HEALTHCARE (TEMPLE EWELL) LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 MARCH 2026
14. | CONTROLLING PARTY
The Company is controlled by Crownwood Healthcare (Holdings) Limited (registered office: Century House, Nicholson Road, Torquay, TQ2 7TD, England, United Kingdom), by way of their 100% shareholding.
Page 13